aTyr Pharma, Inc. (NASDAQ:LIFE – Get Rating) – Research analysts at HC Wainwright upped their FY2026 EPS estimates for shares of aTyr Pharma in a report issued on Wednesday, May 10th. HC Wainwright analyst J. Pantginis now forecasts that the biotechnology company will post earnings of $0.68 per share for the year, up from their […]
aTyr Pharma (NASDAQ:LIFE – Get Rating) will release its earnings data on Tuesday, May 9th. aTyr Pharma (NASDAQ:LIFE – Get Rating) last released its quarterly earnings results on Thursday, March 9th. The biotechnology company reported ($0.26) EPS for the quarter, topping the consensus estimate of ($0.48) by $0.22. The firm had revenue of $10.39 million […]
aTyr Pharma (NASDAQ:LIFE – Get Rating) will be releasing its earnings data on Tuesday, May 9th. aTyr Pharma (NASDAQ:LIFE – Get Rating) last posted its quarterly earnings data on Thursday, March 9th. The biotechnology company reported ($0.26) EPS for the quarter, topping the consensus estimate of ($0.48) by $0.22. The company had revenue of $10.39 […]
aTyr Pharma, Inc. (NASDAQ:LIFE – Get Rating) has received a consensus recommendation of “Moderate Buy” from the six ratings firms that are presently covering the firm, Marketbeat Ratings reports. One research analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. The average 12 month target […]
aTyr Pharma (NASDAQ:LIFE – Get Rating) had its price target hoisted by Piper Sandler from $9.00 to $13.00 in a research report sent to investors on Tuesday, The Fly reports. The firm currently has an overweight rating on the biotechnology company’s stock. A number of other equities analysts also recently issued reports on the company. […]